Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
-
ETF
Equity
- years
48 holdings
$29.18
Price+1.65%
$0.48
$75.454m
Small
$19.764k
Avg Volume$47.940m
$27.95
NAV0.75%
Expense Ratio2.50%
Yield$0.73
Dividend